Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031

Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031

Dec 23, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Modular Medical Announces Licensing and Partnership Agreement With Nudge BG was announced by AccessWire.com, 19 December 2024. Modular Medical, Inc., an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs...
Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes

Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes

Dec 9, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Insulet awarded $452M in EOFlow patent fight by Elise Reuter for MedTechDive.com, 5 December 2024. Insulet sued EOFlow and three former executives who joined the South Korea-based patch-pump maker, claiming the company “launched a plan to brazenly copy Insulet’s...
Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Savvy Updates, 12/2/24: Embecta Discontinues FDA-Approved Insulin Patch Pump, Levothyroxine & Bone Loss, Skin Patch to Measure Blood Pressure, eddii Virtual Diabetes Care

Dec 2, 2024 | Diabetes Business, Featured, Research News, Technology Updates

Embecta discontinues insulin patch pump development by Elise Reuter for MedTechDive.com, 26 November 2024. Embecta said it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The...
Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Nov 25, 2024 | Advocacy, Diabetes Business, Eating, Featured, Research News, Technology Updates, Videos

In this week’s issue of The Savvy Diabetic:  FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Skip to content